I. Kalomenidis

发表

Application of a home-based exercise program combined with tele-rehabilitation in previously hospitalized patients with COVID-19: A feasibility, single-cohort interventional study

H. Milionis, E. Kortianou, Dimitrios Tsimouris, 2022, Pneumon.

Osteopontin is upregulated in malignant and inflammatory pleural effusions

C. Roussos, I. Kalomenidis, S. Papiris, 2009, Respirology.

The angiopoietin/Tie2 axis mediates malignant pleural effusion formation.

C. Roussos, A. Papapetropoulos, I. Kalomenidis, 2009, Neoplasia.

Angiopoietin-2 levels are elevated in exudative pleural effusions.

C. Roussos, A. Papapetropoulos, I. Kalomenidis, 2006, Chest.

The Medical Research Council chronic dyspnea score predicts the survival of patients with idiopathic pulmonary fibrosis.

Z. Daniil, C. Roussos, I. Kalomenidis, 2008, Respiratory medicine.

Versican modulates tumor-associated macrophage properties to stimulate mesothelioma growth

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2018, Oncoimmunology.

Kinetics of Nucleocapsid, Spike and Neutralizing Antibodies, and Viral Load in Patients with Severe COVID-19 Treated with Convalescent Plasma

M. Dimopoulos, A. Kotanidou, S. Papageorgiou, 2021, Viruses.

Specific effects of bortezomib against experimental malignant pleural effusion: a preclinical study

C. Roussos, I. Kalomenidis, T. Blackwell, 2010, Molecular Cancer.

Patterns of drug resistance among patients with tuberculous pleural effusion in Greece.

I. Marinou, S. Tsikrika, I. Kalomenidis, 2017, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Cough and fever in a female with Crohn's disease receiving infliximab

V. Papas, C. Roussos, I. Kalomenidis, 2005, European Respiratory Journal.

Host-derived interleukin-5 promotes adenocarcinoma-induced malignant pleural effusion.

B. Fingleton, C. Roussos, R. Peebles, 2010, American journal of respiratory and critical care medicine.

Animal models of malignant pleural effusion

I. Kalomenidis, G. Stathopoulos, 2009, Current opinion in pulmonary medicine.

Pleurotoxic Drugs—an Update: Someone Else to Blame?

I. Kalomenidis, V. Skouras, 2019, Current Pulmonology Reports.

Etanercept-induced pleuropericardial lupus-like syndrome

I. Porfyridis, C. Roussos, I. Kalomenidis, 2009, European Respiratory Journal.

A sulindac analogue is effective against malignant pleural effusion in mice.

C. Roussos, I. Kalomenidis, S. Papiris, 2011, Lung cancer.

Dry cough and dyspnoea rapidly increasing to respiratory failure in a male smoker

C. Roussos, I. Kalomenidis, K. Malagari, 2005, European Respiratory Journal.

Drug resistance in patients with tuberculous pleural effusions

I. Kalomenidis, V. Skouras, 2018, Current opinion in pulmonary medicine.

Eosinophilic pleural effusions.

I. Kalomenidis, R. Light, 2003, Current opinion in pulmonary medicine.

Tracheal compression in Marfan syndrome.

I. Kalomenidis, S. Papiris, E. Manali, 2008, Internal medicine.

Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma

G. Kollias, S. Zakynthinos, V. Soumelis, 2019, Nature Communications.

Zoledronic acid is effective against experimental malignant pleural effusion.

C. Roussos, Zongmin Zhou, I. Kalomenidis, 2008, American journal of respiratory and critical care medicine.

Mammalian target of rapamycin (mTOR) inhibition does not prevent lung adenocarcinoma‐induced malignant pleural effusion

I. Kalomenidis, M. Vazakidou, C. Moschos, 2014, Respirology.

Tumor necrosis factor-alpha promotes malignant pleural effusion.

C. Roussos, I. Kalomenidis, T. Blackwell, 2007, Cancer research.

Secreted phosphoprotein-1 directly provokes vascular leakage to foster malignant pleural effusion

C. Roussos, N. Maniatis, M. Kardara, 2013, Oncogene.

Mast cells mediate malignant pleural effusion formation.

V. Aidinis, O. Eickelberg, Y. Iwakura, 2015, The Journal of clinical investigation.

Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice.

S. Zakynthinos, A. Papapetropoulos, Sofia-Iris Bibli, 2015, American journal of physiology. Lung cellular and molecular physiology.

Beneficial Impact of CCL2 and CCL12 Neutralization on Experimental Malignant Pleural Effusion

I. Kalomenidis, L. A. Snyder, I. Giopanou, 2013, PloS one.

Bench-to-bedside review: Pulmonary–renal syndromes – an update for the intensivist

C. Roussos, I. Kalomenidis, A. Karakatsani, 2007, Critical care.

Polymyositis Rheumatoid arthritis Mixed collagen vascular disease Pulmonary – renal syndrome in thrombotic microangiopathy Antiphospholipid syndrome Thrombotic thrombocytopenic purpura Infections Neoplasms

C. Roussos, I. Kalomenidis, A. Karakatsani, 2022 .

Nasal high-flow oxygen versus noninvasive ventilation in acute exacerbation of COPD: protocol for a randomised noninferiority clinical trial

Z. Daniil, K. Gourgoulianis, S. Zakynthinos, 2020, ERJ Open Research.

Depression, Insomnia and Post-Traumatic Stress Disorder in COVID-19 Survivors: Role of Gender and Impact on Quality of Life

Z. Barmparessou, I. Kalomenidis, P. Katsaounou, 2022, Journal of personalized medicine.

Prognostic value of C‐reactive protein in parapneumonic effusions

Z. Daniil, K. Gourgoulianis, I. Kalomenidis, 2012, Respirology.

Dexamethasone acutely accelerates pleural fluid absorption in mice hydrothoraces

K. Gourgoulianis, C. Hatzoglou, I. Kalomenidis, 2010, The Journal of Physiological Sciences.

Can pharmacologic agents speed the rate of resorption of pleural fluid?

I. Kalomenidis, S. Zarogiannis, 2015, Current opinion in pulmonary medicine.

Beyond talc pleurodesis: Do we really need new methods?

I. Kalomenidis, 2011, Respirology.

Targeting Tie-2/angiopoietin axis in experimental mesothelioma confers differential responses and raises predictive implications

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2018, Oncotarget.

Vascular endothelial growth factor levels in post-CABG pleural effusions are associated with pleural inflammation and permeability.

C. Roussos, I. Kalomenidis, T. Blackwell, 2007, Respiratory medicine.

Pleurodesis is inhibited by anti-vascular endothelial growth factor antibody.

I. Kalomenidis, R. Light, K. Lane, 2005, Chest.

Pathogenesis of the eosinophilic pleural effusions

I. Kalomenidis, R. Light, 2004, Current opinion in pulmonary medicine.

Bacteriology, antibiotic resistance and risk stratification of patients with culture-positive, community-acquired pleural infection

I. Kalomenidis, I. Sigala, Stelios Xitsas, 2021, Journal of thoracic disease.

Effect of anakinra on mortality in patients with COVID-19: a systematic review and patient-level meta-analysis

M. Netea, G. Chatellier, M. Sormani, 2021, The Lancet Rheumatology.

Convalescent plasma therapy in an immunocompromised patient with multiple COVID‐19 flares: a case report

I. Kalomenidis, M. Pagoni, E. Jahaj, 2021, Respirology case reports.

Diagnostic accuracy of biomarkers of oxidative stress in parapneumonic pleural effusions

K. Kostikas, M. Minas, K. Gourgoulianis, 2011, European journal of clinical investigation.

A 35-year-old male with chronic cough

C. Roussos, I. Kalomenidis, G. Stathopoulos, 2007, European Respiratory Journal.

Effect of COVID-19-Related Lockdown οn Hospital Admissions for Asthma and COPD Exacerbations: Associations with Air Pollution and Patient Characteristics

E. Zervas, I. Kalomenidis, I. Sigala, 2021, Journal of personalized medicine.

Combined Expression of p53, Bcl-2, and p21WAF-1 Proteins in Lung Cancer and Premalignant Lesions: Association with Clinical Characteristics

C. Roussos, I. Kalomenidis, G. Papamichalis, 2001, Lung.

Early Anakinra Treatment for COVID-19 Guided by Urokinase Plasminogen Receptor

S. Ktena, E. Nicastri, L. Dagna, 2021, medRxiv.

Early Treatment of COVID-19 Pneumonia with Anakinra Guided by Urokinase Plasminogen Receptor

M. Netea, S. Ktena, G. Ippolito, 2021 .

Chylothorax: diagnostic approach

I. Kalomenidis, V. Skouras, 2010, Current opinion in pulmonary medicine.

Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19

Karla P. Zepeda, Christina C. Chang, Kamil H A Kim, 2022, Annals of Internal Medicine.

Mortality rate among critically ill patients with COVID-19 in a medical system with adequate hospital resources: a prospective observational study

S. Zakynthinos, A. Kotanidou, I. Kalomenidis, 2020 .

Interleukin‐17A is involved in bacteria‐related acute pleural inflammation

J. M. Porcel, I. Kalomenidis, C. Moschos, 2013, Respirology.

Clinical features and outcomes of hospitalized COVID-19 patients in a low burden region

I. Kalomenidis, E. Mylona, Margellou Evangelia, 2020, Pathogens and global health.

Pneumothorax-associated pleural eosinophilia in mice is interleukin-5 but not interleukin-13 dependent.

R. Peebles, I. Kalomenidis, J. Elias, 2005, Chest.

Moderate COVID-19: Clinical Trajectories and Predictors of Progression and Outcomes

I. Kalomenidis, A. Panagopoulos, I. Papanikolaou, 2022, Journal of personalized medicine.

Malignant mesothelioma cells secrete natriuretic peptides: Data and diagnostic clinical implications

Z. Daniil, K. Gourgoulianis, I. Kalomenidis, 2020, Respirology.

Pneumothorax‐associated pleural eosinophilia is tumour necrosis factor‐alpha‐dependent and attenuated by steroids

C. Roussos, I. Kalomenidis, R. Light, 2007, Respirology.

Association of sleep duration and quality with immunological response after vaccination against severe acute respiratory syndrome coronavirus‐2 infection

E. Kaimakamis, C. Alexopoulou, I. Kalomenidis, 2022, Journal of sleep research.

CSF1/CSF1R Axis Blockade Limits Mesothelioma and Enhances Efficiency of Anti-PDL1 Immunotherapy

I. Kalomenidis, K. Psarra, S. Magkouta, 2021, Cancers.

CSF1/CSF1R signaling mediates malignant pleural effusion formation

I. Kalomenidis, K. Psarra, S. Magkouta, 2022, JCI insight.

Matrix Metalloproteinase Levels in the Differentiation of Parapneumonic Pleural Effusions

K. Kostikas, K. Gourgoulianis, I. Kalomenidis, 2010, Respiration.

Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo

I. Kalomenidis, C. Moschos, I. Psallidas, 2015, Respirology.

Eotaxin-3 and interleukin-5 pleural fluid levels are associated with pleural fluid eosinophilia in post-coronary artery bypass grafting pleural effusions.

R. Peebles, I. Kalomenidis, T. Blackwell, 2005, Chest.

Pleural fluid levels of vascular cell adhesion molecule-1 are elevated in eosinophilic pleural effusions.

R. Peebles, I. Kalomenidis, R. Light, 2003, Chest.

Increased Indoleamine-2,3-Dioxygenase Activity Is Associated With Poor Clinical Outcome in Adults Hospitalized With Influenza in the INSIGHT FLU003Plus Study

T. Griffin, R. Dewar, J. Metcalf, 2017, Open forum infectious diseases.

Malignant pleural effusion: from bench to bedside

J. M. Porcel, I. Kalomenidis, Ioannis Psallidas, 2016, European Respiratory Review.

A six-year microbiologic study of hospital-acquired and health-care associated parapneumonic pleural infection.

I. Kalomenidis, V. Skouras, O. Kotsiou, 2019, European journal of internal medicine.

Comparison of the Outcomes of Individuals With Medically Attended Influenza A and B Virus Infections Enrolled in 2 International Cohort Studies Over a 6-Year Period: 2009–2015

R. Schooley, E. Maltezos, Tak-chiu Wu, 2017, Open forum infectious diseases.

Author Correction: Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, E. Nicastri, 2021, Nature medicine.

Kinetics of Immune Subsets in COVID-19 Patients Treated with Corticosteroids

I. Kalomenidis, K. Psarra, A. Tsirogianni, 2022, Viruses.

Transforming growth factor-beta3 induces pleurodesis in rabbits and collagen production of human mesothelial cells.

I. Kalomenidis, R. Light, K. Lane, 2005, Chest.

A 27-Year-Old Man With Intermittent Chest Pain During the Last 4 Years.

I. Kalomenidis, K. Athanassiadi, A. Argyropoulou, 2021, Chest.

Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial

M. Netea, S. Ktena, G. Ippolito, 2021, Nature Medicine.

Iodopovidone is as effective as doxycycline in producing pleurodesis in rabbits

I. Kalomenidis, R. Light, K. Lane, 2010, Respirology.

Extranodal marginal zone B-cell lymphoma of the lung in Sjögren's syndrome patients: reappraisal of clinical, radiological, and pathology findings.

C. Roussos, D. Rontogianni, I. Kalomenidis, 2007, Respiratory medicine.

Osteopontin drives KRAS-mutant lung adenocarcinoma.

I. Kalomenidis, V. Panoutsakopoulou, A. Lamort, 2019, Carcinogenesis.

Growth factors in pleural fibrosis

S. Mutsaers, I. Kalomenidis, Y. Lee, 2006, Current opinion in pulmonary medicine.

A Giant solitary fibrous tumour resected through median sternotomy

I. Kalomenidis, P. Katsaounou, K. Athanassiadi, 2022, Respirology case reports.

Pleural fluid tests to diagnose tuberculous pleuritis

I. Kalomenidis, V. Skouras, 2016, Current opinion in pulmonary medicine.

Octreotide and chylothorax

I. Kalomenidis, 2006, Current opinion in pulmonary medicine.

Allergic inflammation does not impact chemical-induced carcinogenesis in the lungs of mice

C. Roussos, S. Zakynthinos, I. Kalomenidis, 2010, Respiratory research.

Nuclear Factor-κB Affects Tumor Progression in a Mouse Model of Malignant Pleural Effusion

Richard W. Light, Timothy S. Blackwell, Fiona E. Yull, 2006 .

A central role for tumor-derived monocyte chemoattractant protein-1 in malignant pleural effusion.

I. Porfyridis, C. Roussos, Zongmin Zhou, 2008, Journal of the National Cancer Institute.

PLEURAL EFFUSIONS | Chylothorax, Pseudochylothorax, LAM, and Yellow Nail Syndrome

I. Kalomenidis, Y. Lee, 2006 .

Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial

Christina C. Chang, J. Thakuria, N. Gerry, 2022, The Lancet.

Icmt inhibition exerts anti-angiogenic and anti-hyperpermeability activities impeding malignant pleural effusion

I. Kalomenidis, C. Moschos, K. Psarra, 2016, Oncotarget.

DRUG RELATED PLEURAL DISEASE

I. Kalomenidis, 2010 .

Wnt1 silences chemokine genes in dendritic cells and induces adaptive immune resistance in lung adenocarcinoma

G. Kollias, S. Zakynthinos, V. Soumelis, 2019, Nature Communications.

MTH1 favors mesothelioma progression and mediates paracrine rescue of bystander endothelium from oxidative damage.

V. Gorgoulis, I. Kalomenidis, C. Moschos, 2020, JCI insight.

Opposing effects of bortezomib-induced nuclear factor-κB inhibition on chemical lung carcinogenesis.

C. Roussos, S. Zakynthinos, L. Gleaves, 2012, Carcinogenesis.

Neutralization of tumor necrosis factor bioactivity ameliorates urethane-induced pulmonary oncogenesis in mice.

C. Roussos, S. Zakynthinos, I. Kalomenidis, 2011, Neoplasia.

Interleukin-18 is up-regulated in infectious pleural effusions.

I. Kalomenidis, N. Rovina, C. Moschos, 2013, Cytokine.

Diabetes and COVID-19; A Bidirectional Interplay

M. Dimopoulos, I. Kalomenidis, V. Lambadiari, 2022, Frontiers in Endocrinology.

Paracetamol and ibuprofen block hydrothorax absorption in mice.

K. Gourgoulianis, C. Zisis, I. Kalomenidis, 2015, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

Diffuse Alveolar Infiltrates and Macroscopic Hematuria: A Run-and-Gun Affair

L. Nakopoulou, I. Kalomenidis, S. Papiris, 2010, Respiration.

A young male with chest pain, cough and fever

Z. Daniil, C. Roussos, I. Kalomenidis, 2004, European Respiratory Journal.

Malignant pleural effusion: tumor-host interactions unleashed.

I. Kalomenidis, G. Stathopoulos, 2012, American journal of respiratory and critical care medicine.

Tumor Necrosis Factor-α Promotes Malignant Pleural Effusion

C. Roussos, I. Kalomenidis, T. Blackwell, 2007 .

Pattern and Risk Factors of Liver Injury among Hospitalized Covid-19 Patients: The Experience of a Greek Referral Hospital

I. Kalomenidis, M. Vraka, Georgios Karampekos, 2021 .

Role of angiopoietins in mesothelioma progression.

I. Kalomenidis, M. Spella, G. Stathopoulos, 2019, Cytokine.

Can Coagulation System Disorders and Cytokine and Inflammatory Marker Levels Predict the Temporary Clinical Deterioration or Improvement of Septic Patients on ICU Admission?

S. Zakynthinos, I. Siempos, I. Kalomenidis, 2021, Journal of clinical medicine.

A Phase II Study on the Use of Convalescent Plasma for the Treatment of Severe COVID-19- A Propensity Score-Matched Control Analysis

M. Dimopoulos, A. Kotanidou, S. Papageorgiou, 2021, Microorganisms.

Anti-influenza hyperimmune intravenous immunoglobulin for adults with influenza A or B infection (FLU-IVIG): a double-blind, randomised, placebo-controlled trial

R. Schooley, R. Dewar, J. Metcalf, 2019, The Lancet. Respiratory medicine.

COVID-19 Advanced Care

I. Kalomenidis, P. Steiropoulos, E. Fouka, 2021, Journal of personalized medicine.

Efficacy and safety of early soluble urokinase plasminogen receptor plasma-guided anakinra treatment of COVID-19 pneumonia: A subgroup analysis of the SAVE-MORE randomised trial

E. Nicastri, L. Dagna, H. Milionis, 2022, eClinicalMedicine.

Interferon gamma-induced protein 10 (IP-10) for the early prognosis of the risk for severe respiratory failure and death in COVID-19 pneumonia

K. Syrigos, E. Nicastri, L. Dagna, 2022, Cytokine.

Outcomes of hospitalized COVID-19 patients belonging to ethnic/racial minorities in Greece

A. Panagopoulos, I. Kalomenidis, G. Stavropoulou, 2022, Pneumon.

Pleural effusion osmolality correlation with pH and glucose level of pleural fluid and its effects on the pleural membrane permeability

K. Gourgoulianis, C. Hatzoglou, I. Kalomenidis, 2020, Respiratory Physiology & Neurobiology.

Interleukin-27 improves the ability of adenosine deaminase to rule out tuberculous pleural effusion regardless of pleural tuberculosis prevalence

K. Gourgoulianis, I. Kalomenidis, I. Psallidas, 2015, Infectious diseases.

Recurrent Hemoptysis in a Patient with Previous Tuberculosis

I. Kalomenidis, E. Manali, S. Papiris, 2008, Respiration.

P.0797 Effects on mental health, sleep and quality of life in hospitalized patients with COVID-19 infection

Z. Barmparessou, I. Kalomenidis, P. Katsaounou, 2021, European Neuropsychopharmacology.

Nuclear factor-kappaB affects tumor progression in a mouse model of malignant pleural effusion.

D. Mitchell, I. Kalomenidis, T. Blackwell, 2006, American journal of respiratory cell and molecular biology.

Sputum carcinoembryonic antigen, neuron‐specific enolase and cytokeratin fragment 19 levels in lung cancer diagnosis

C. Roussos, M. Papadakis, I. Kalomenidis, 2004, Respirology.

Primary squamous cell carcinoma of the pleura treated with nivolumab

I. Kalomenidis, I. Sigala, N. Alevizopoulos, 2020, Respirology case reports.

Patient with bilateral pleural effusion: are the findings the same in each fluid?

I. Kalomenidis, R. Light, Rita Gupta, 2003, Chest.

Hospital Resources May Be an Important Aspect of Mortality Rate among Critically Ill Patients with COVID-19: The Paradigm of Greece

S. Zakynthinos, A. Kotanidou, I. Kalomenidis, 2020, Journal of clinical medicine.

Deciphering the link between COPD and lung cancer: Cigarette smoke-induced immunosuppression at the crossroads between cancer immune surveillance and escape

C. Roussos, S. Zakynthinos, D. Rontogianni, 2015 .

Relationship between hypercoagulability of hospitalized patients with COVID-19 disease with the clinical course of the disease as determined by the method of rotational thromboelastometry(ROTEM).

I. Kalomenidis, D. Korakakis, M. Politou, 2022, 10.01 - Respiratory infections and bronchiectasis.

Mast cells mediate malignant pleural effusion formation.

V. Aidinis, O. Eickelberg, Y. Iwakura, 2015, The Journal of clinical investigation.

Comparison of the effects of e-cigarette vapor with cigarette smoke on lung function and inflammation in mice.

S. Zakynthinos, A. Papapetropoulos, Sofia-Iris Bibli, 2018, American journal of physiology. Lung cellular and molecular physiology.

Cyanoacrylate-related pulmonary embolism following percutaneous varicocele embolization.

I. Kalomenidis, E. Brountzos, S. Papiris, 2008, Southern medical journal.